Race Oncology Ltd (RAC) — Capital Reinvestment Ratio
Latest as of December 2024:
0.00x
Race Oncology Ltd (RAC) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow (AU$570.64K) in capital expenditures (AU$4.00). See RAC FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
AU$570.64K
AUD
Capital Expenditures
AU$4.00
AUD
Data as of
Dec 2024
Most recent filing
Race Oncology Ltd Capital Reinvestment Ratio (2011–2013)
This chart tracks Race Oncology Ltd's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Race Oncology Ltd (2011–2013)
Year-by-year Capital Reinvestment Ratio for Race Oncology Ltd from 2011 to 2013. For live market cap and broader valuation context, see Race Oncology Ltd (RAC) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2013 | 0.01x | AU$3.71 Million | AU$31.00K | ▼ -74.4% |
| 2012 | 0.03x | AU$6.68 Million | AU$218.00K | ▲ +439.7% |
| 2011 | 0.01x | AU$11.92 Million | AU$72.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow